Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AI for targeted polypharmacology: The next frontier in drug discovery
Anna Cichońska, Balaguru Ravikumar, Rayees Rahman
Current Opinion in Structural Biology (2024) Vol. 84, pp. 102771-102771
Closed Access | Times Cited: 22

Showing 22 citing articles:

The Role of AI in Drug Discovery
M.K.G. Abbas, Abrar Rassam, Fatima Karamshahi, et al.
ChemBioChem (2024) Vol. 25, Iss. 14
Open Access | Times Cited: 11
Two heads are better than one: Unravelling the potential Impact of Artificial Intelligence in nanotechnology
Gaurav Gopal Naik, Vijay A. Jagtap
Nano TransMed (2024) Vol. 3, pp. 100041-100041
Open Access | Times Cited: 8
Advanced AI and ML frameworks for Transforming Drug Discovery and Optimization: With Innovative insights in Polypharmacology, Drug Repurposing, Combination Therapy and Nanomedicine.
Subiya Ambreen, Mohammad Umar, Asra Noor, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117164-117164
Closed Access | Times Cited: 8
Toward structure–multiple activity relationships (SMARts) using computational approaches: A polypharmacological perspective
Edgar López‐López, José L. Medina‐Franco
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104046-104046
Closed Access | Times Cited: 6
Advanced AI Applications for Drug Discovery
Bancha Yingngam, Benjabhorn Sethabouppha
Advances in medical technologies and clinical practice book series (2024), pp. 42-86
Closed Access | Times Cited: 4
Advances in physiological and clinical relevance of hiPSC-derived brain models for precision medicine pipelines
Negin Imani Farahani, Lisa Lin, Shama Nazir, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 18
Open Access
Allostery
Mateu Montserrat‐Canals, Gabriele Cordara, Ute Krengel
Quarterly Reviews of Biophysics (2025) Vol. 58
Closed Access
Decoding Neural Circuit Dysregulation in Bipolar Disorder: Toward an Advanced Paradigm for Multidimensional Cognitive, Emotional, and Psychomotor Treatment
Luca Steardo, Martina D’Angelo, Francesco Monaco, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 169, pp. 106030-106030
Open Access
Artificial Intelligence: Preface, Applications and Future Perspective in Relation to Pharmaceutical Sector
Supriya Singh, Sanket Kumar, Sheikh Shahnawaz Quadir, et al.
Journal of Pharmaceutical Innovation (2025) Vol. 20, Iss. 2
Closed Access
Artificial Intelligence-Based Methods for Drug Repurposing and Development in Cancer
Sara Herráiz-Gil, Elisa Nygren-Jiménez, Diana N. Acosta-Alonso, et al.
Applied Sciences (2025) Vol. 15, Iss. 5, pp. 2798-2798
Open Access
Modeling and Interpretability Study of the Structure–Activity Relationship for Multigeneration EGFR Inhibitors
Zhiqi Sun, Donghui Huo, Jiangyu Guo, et al.
ACS Omega (2025)
Open Access
Polypharmacology: new drugs in 2023–2024
Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports (2025)
Open Access
Advances in artificial intelligence-envisioned technologies for protein and nucleic acid research
Amol D. Gholap, Abdelwahab Omri
Drug Discovery Today (2025), pp. 104362-104362
Open Access
Exploring the Promise and Challenges of Artificial Intelligence in Biomedical Research and Clinical Practice
Raffaele Altara, Cameron J. Basson, Giuseppe Biondi‐Zoccai, et al.
Journal of Cardiovascular Pharmacology (2024) Vol. 83, Iss. 5, pp. 403-409
Closed Access | Times Cited: 2
Developing a Semi-Supervised Approach Using a PU-Learning-Based Data Augmentation Strategy for Multitarget Drug Discovery
Yang Hao, Bo Li, Daiyun Huang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8239-8239
Open Access | Times Cited: 1
The “Doorstop Pocket” In Thioredoxin Reductases─An Unexpected Druggable Regulator of the Catalytic Machinery
Matteo Ardini, Samuel Yaw Aboagye, Valentina Petukhova, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 15947-15967
Closed Access | Times Cited: 1
Complex Inhibitory Activity of Pentacyclic Triterpenoids against Cutaneous Melanoma In Vitro and In Vivo: A Literature Review and Reconstruction of Their Melanoma-Related Protein Interactome
Arseny D. Moralev, Marina A. Zenkova, Andrey V. Markov
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 11, pp. 3358-3384
Open Access | Times Cited: 1
How to address the complexity of multi-targeted drug discovery for Alzheimer’s disease?
Juan F. González, J.M. Sánchez-Montero
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 10, pp. 1149-1152
Open Access
Delineating Drug Class and Target-Specific Adverse Events of Kinase Inhibitors
Annalise Schweickart, Juhi Somani, Ryan Theisen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
AI in Predictive Toxicology
Bancha Yingngam
Advances in medical technologies and clinical practice book series (2024), pp. 79-134
Closed Access
Perry Disease: Current Outlook and Advances in Drug Discovery Approach to Symptomatic Treatment
Z Gajda, Magdalena Hawrylak, Jadwiga Handzlik, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10652-10652
Open Access
Rethinking the 'Best Method' Paradigm: The Effectiveness of Hybrid and Multidisciplinary Approaches in Chemoinformatics
José L. Medina‐Franco, Johny R. Rodríguez-Pérez, H. Hernández, et al.
Artificial Intelligence in the Life Sciences (2024), pp. 100117-100117
Open Access
Page 1

Scroll to top